Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues

Saved in:

Bibliographic Details
Published in:	Expert review of clinical pharmacology Vol. 16; no. 3; p. 177
Main Authors:	Leung, Jonathan G, Ehret, Megan, Love, Raymond C, Cotes, Robert O
Format:	Journal Article
Language:	English
Published:	England 04-03-2023
Subjects:	Clozapine Humans Risk Assessment Risk Management United States United States Food and Drug Administration United States
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1751-2441
DOI:	10.1080/17512433.2023.2183192